Trial intelligence / Profile preview

NARLAL: Navelbine and Radiotherapy in NSCLC

NCT00887783Phase 2Completed

Sponsor
University Hospital Odense
Start
May 2009
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by University Hospital Odense. Started May 2009; status: completed.

02

Drugs

vinorelbine
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00887783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00887783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call